InterStim® Amplitude Study

NCT03335761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2021-01-08

Study results available
· View outcomes & findings →

Summary

This feasibility study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).

Conditions

  • Urinary Urge Incontinence

Interventions

DEVICE

InterStim Therapy

Device Programming

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-27
Primary Completion
2019-11-06
Completion
2019-11-06
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Canada
  • France
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335761 on ClinicalTrials.gov